Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref‐1 in thyroid cancer cells: A novel tumorigenic pathway
- 1 June 2006
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 209 (1) , 44-55
- https://doi.org/10.1002/jcp.20704
Abstract
Nucleotide receptors signaling affects cell proliferation, with possible implications on tumorigenic processes. However, molecular targets and action mechanisms of the extracellular nucleotides are still poorly elucidated. We have previously shown in ARO cells that APE1/Ref‐1, a transcriptional coactivator responsible for the maintenance of the cellular proliferative rate, is functionally controlled by P2‐mediated signaling. Here, we demonstrate that extracellular ATP has a mitogenic effect on ARO cells, increasing ERK phosphorylation, AP1 activation, and cyclin D1 expression. Using the ATP/ADPase apyrase and the P2 receptor antagonist suramin, we show that the extracellular ATP, physiologically released by ARO cells, exerts mitogenic effects. A differential proteomic approach was used to identify molecular events associated with the ATP‐induced cell proliferation. Among other proteins, Hsp90 was found upregulated upon ATP stimulation. Pretreatment with suramin completely blocked the ATP‐induced Hsp90 activation, confirming the involvement of cell‐surface P2 nucleotide receptors in the ATP‐mediated activation of ARO cells. Treatment of proliferating ARO cells with suramin and apyrase significantly reduced the intracellular levels of Hsp90, suggesting an autocrine/paracrine mechanism of control on Hsp90 expression by extracellular ATP. The influence of Hsp90 on ATP‐induced cell proliferation was also demonstrated by its specific inhibition with 17‐AAG. The molecular pathway by which ATP stimulates cell proliferation was further investigated by siRNA strategies showing that Hsp90 is a target of APE1/Ref‐1 functional activation. Stimulation of ARO cells with specific nucleotide receptors agonists evidenced a major involvement of P2Y1and P2Y2receptors in controlling the Hsp90 activation. Accordingly, these two receptors resulted significantly upregulated in sample biopsies from different thyroid tumors. J. Cell. Physiol. 209: 44–55, 2006.Keywords
This publication has 54 references indexed in Scilit:
- Inhibition of Heat Shock Protein 90, a Novel RET/PTC1-associated Protein, Increases Radioiodide Accumulation in Thyroid CellsJournal of Biological Chemistry, 2004
- Regulation of bone resorption and formation by purines and pyrimidinesTrends in Pharmacological Sciences, 2003
- Is there a basis for distinguishing two types of P2-purinoceptor?Published by Elsevier ,2002
- AP-1 as a regulator of cell life and deathNature Cell Biology, 2002
- Extracellular ATPGeneral Pharmacology: The Vascular System, 1998
- Purinergic agonist ATP is a comitogen in thyroid FRTL-5 cellsJournal of Cellular Physiology, 1996
- Parallel signal processing among mammalian MAPKsTrends in Biochemical Sciences, 1995
- ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGFCell, 1991
- Extracellular ATP-induced production of hydrogen peroxide in porcine thyroid cellsJournal of Endocrinology, 1990
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976